Structure-activity relationships of rgd mimetics as fibrinogen-receptor antagonists

Bioscience, Biotechnology and Biochemistry

Volumn 63, Issue 10, 1999, Pages 1684-1690

  Miyashita, Masahiro ^a   Akamatsu, Miki ^a   Ueno, Hideki ^a   Nakagawa, Yoshiaki ^a   Nishimura, Keiichiro ^b   Hayashi, Yoshio ^c   Sato, Yoshimi ^c   Ueno, Tamio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Osaka Prefecture University   (Japan)

^c NIPPON STEEL CORPORATION   (Japan)

Author keywords

Antithrombotic; Arg Gly Asp; Fibrinogen antagonist; GPIIb IIIa; Peptide mimetic

Indexed keywords

ARGINYL-GLYCYL-ASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; FIBRINOGEN; FIBRINOGEN RECEPTOR; FIBRINOLYTIC AGENT; OLIGOPEPTIDE;

ARTICLE; CHEMICAL MODEL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; IC 50; KINETICS; METABOLISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS; THROMBOCYTE; THROMBOCYTE AGGREGATION;

BLOOD PLATELETS; FIBRINOGEN; FIBRINOLYTIC AGENTS; HUMANS; INHIBITORY CONCENTRATION 50; KINETICS; MODELS, CHEMICAL; OLIGOPEPTIDES; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033202939     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.63.1684     Document Type: Article

References (29)

1. Coller, B. S., Platelets and thrombolytic therapy. N. Engl. J. Med., 322, 33-42 (1990).
2. Hynes, R. O., Integrins: A family of cell surface receptors. Cell, 48, 549-554 (1987).
3. Marguerie, G. A., Thomas-Maison, N., Ginsbarg, M. H., and Plow, E. F., The platelet-fibrinogen interaction: Evidence for proximity of the Aa chain of fibrinogen to platelet membrane glycoproteins Ilb/III. Eur. J. Biochem., 139, 5-11 (1984).
4. Ruoslahti, E. and Pierschbacher, M. D., New perspectives in cell adhesion. Science, 283, 491-497 (1987).
5. Plow, E. F., Pierschbacher, M. D., Ruoslahti, E., Marguerie, G. A., and Ginsbarg, M. H., The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc. Natl. Acad. Sei. USA, 82, 8057-8061 (1985).
6. Gartner, T. K. and Bennett, J. S., The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J. Biol. Chem., 260, 11891-11894(1985).
7. Samanen, J., Ali, F., Romoff, T., Calvo, R., Sorenson, E., Vasko, J., Störer, B., Berry, D., Bennet, D., Strohsacker, M., Powers, D., Stadel, J., and Nichols, A., Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro. J. Med. Chem., 34, 3114-3125 (1991).
8. Alig, L., Edenhofer, A., Hadvâry, P., Hürzeler, M., Knopp, D., Müller, M., Steiner, B., Trzeciak, A., and Weller, T., Low molecular weight, non-peptide fibrinogen receptor antagonists. J. Med. Chem., 35, 4393-4407 (1992).
9. D’Souza, S. E., Ginsberg, M. H., Burke, T. A., Lam, S. C.-T., and Plow, E. F., Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science, 242, 91-93 (1988).
10. Zablocki, J. A., Miyano, M., Garland, R. B., Pireh, D., Schretzman, L., Rao, S. N., Lindmar, R. J., Panzer-Knodle, S. G., Nicholson, N. S., Taite, B. B., Salyers, A. K., King, L. W., Campion, J. G., and Feigen, L. P., Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP Ilb-IIIa receptor. J. Med. Chem., 36, 1811-1819 (1993).
11. Stanovnik, B. and Tisler, M., Synthesis of pyridazine derivat-ives-VIII: Imidazo[l,2-b]pyridazines and some tricyclic aza analogs. Tetrahedron, 23, 387-395 (1967).
12. Kobe, J., Stanovnik, B., and Tisler, M., Synthesis of pyridazine derivatives-XV: Some electrophilic substitutions on imidazo[l,2-bjpyridazines. Tetrahedron, 24, 239-245 (1968).
13. Born, G. V. R., Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature, 194, 927-929 (1962).
14. Finney, D. J., Probit Analysis, Cambridge Univ. Press, Cambridge, UK (1952).
15. Goodnight, J. H., In “SAS User’s Guide”, eds. Helwig, J. T., and Council, K. A., SAS Institute, Cary, NC, U.S.A., pp. 357-360 (1979).
16. Markwell, M. A. K., A new solid-state reagent to iodinate proteins. Anal. Biochem., 125, 427-432 (1982).
17. Morii, N., Teru-uchi, T., Tominaga, T., Kumagai, N., Kozaki, S., Ushikubi, F., and Narumiya, S., A rho gene product in human blood platelet II. Effects of the ADP-ribosylation by botulinum C3 ADP-ribosyltransferase on platelet aggregation. J. Biol. Chem., 267, 20921-20926 (1992).
18. Marguerie, G. A., Plow, E. F., and Edgington, T. S., Human platelets possess an inducible and saturable receptor specific for fibrinogen. J. Biol. Chem., 254, 5357-5363 (1979).
19. SYBYL Molecular Modeling Software, Tripos Associates, Inc., St Louis, MO, U.S.A.
20. Stewart, J. J. P., MOP AC Ver. 6, Quantum Chemistry Program Exchange, Program 455, Indiana University, Bloomington, IN, U.S.A.
21. Stewart, J. J. P., J. Compt. Chem., 10, 221-264 (1989).
22. Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Zakrzewski, V. G., Montgomery, J. A., Stratmann, R. E., Burant, J. C., Dapprich, S., Millam, J. M., Daniels, A. D., Kudin, K. N., Strain, M. C., Farkas, O., Tomasi, J., Barone, V., Cossi, M., Cammi, R., Mennucci, B., Pomelli, C., Adamo, C., Clifford, S., Ochterski, J., Petersson, G. A., Ayala, P. Y., Cui, Q., Morokuma, K., Malick, D. K., Rabuck, A. D., Raghavachari, K., Foresman, J. B., Cioslowski, J., Ortiz, J. V., Stefanov, B. B., Liu, G., Liashenko, A., Piskorz, P., Komaromi, L, Gomperts, R., Martin, R. L., Fox, D. J., Keith, T., Al-Laham, M. A., Peng, C. Y., Nanayakkara, A., Gonzalez, C., Challacombe, M., Gill, P. M. W., Johnson, B., Chen, W., Wong, M. W., Andres, J. L., Gonzalez, C., Head-Gordon, M., Replogle, E. S., and Pople, J. A., Gaussian 98, Revision A.5. Gaussian, Inc., Pittsburgh PA, U.S.A. (1998).
23. Akamatsu, M., Ueno, T., and Fujita, T., Application of a new hydrophobicity parameter of amino acid side chains to quantitative structure-activity analyses of oligopeptides. In “Classical and Three-Dimesional QSAR in Agrochemistry”, eds. Hansch, C., and Fujita, T., American Chemical Society, Washington, DC, U.S.A., pp. 229-239 (1995).
24. Blackburn, B. K., Lee, A., Baier, M., Kohl, B., Olivero, A. G., Matamoros, R., Robarge, K. D., and McDowell, R. S., From peptide to non-peptide. 3. Atropisomeric GPIIblHa antagonists containing the 3,4-dihydro-l β-l,4-benzodiazepine-2,5-dione nucleus. J. Med. Chem., 40, 717-729 (1997).
25. Fisher, M. J., Gunn, B., Harms, C. S., Kline, A. D., Mullaney, J. T., Nunes, A., Scarborough, R. M., Artsten, A. E., Skelton, M. A., Um, S. L., Utterback, B. G., and Jakubowski, J. A., Non-peptide RGD surrogates which mimic a Gly-Asp yS-turn: Potent antagonists of platelet glycoprotein Ilb-IIIa. J. Med. Chem., 40, 2085-2101 (1997).
26. Ku, T. W., Miller, W. H., Bondinell, W. E., Erhard, K. F., Keenan, R. M., Nichols, A. J., Peishoff, C. E., Samanen, J. M., Wong, A. S., and Huffman, W. F., Potent non-peptide fibrinogen receptor antagonists which present an alternative pharmacophore. J. Med. Chem., 38, 9-12 (1995).
27. Sugihara, H., Fukushi, H., Miyawaki, T., Imai, Y., Terashita, Z., Kawamura, M., Fujisawa, Y., and Kita, S., Novel non-pep-tide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein Ilb-IIIa antagonistic activities of 1,3,4-trisubstitut-ed 2-oxopiperadine derivatives incorporating side-chain functions of the RGDF peptide. J. Med. Chem., 41, 489-502 (1998).
28. Zablocki, J. A., Rico, J. G., Garland, R. B., Rogers, T. E., Williams, K., Schretzman, L. A., Rao, S. A., Bovy, P. R., Tjoeng, F. S., Lindmark, R. J., Toth, M. V., Zupec, M. E., McMackins, D. E., Adams, S. P., Miyano, M., Markos, C. S., Milton, M. N., Paulton, S., Herin, M., Jacqmin, P., Nicholson, N. S., Panzer-Knodle, S. G., Haas, N. F., Page, J. D., Szalony, J. A., Taite, B. B., Salyers, A. K., King, L. W., Campion, J. G., and Feigen, L. P., Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp sequence of fibrinogen. (Aminobenzamidino)succinyl (ABAS) series of orally active fibrinogen receptor antagonists. J. Med. Chem., 38, 2378-2394 (1995).
29. Topliss, J. G. and Costello, R. J., Chance correlation in structure-activity studies using multiple regression analysis. J. Med. Chem., 15, 1066-1069 (1972).